GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVO) » Definitions » Accounts Payable & Accrued Expense

Alvotech (Alvotech) Accounts Payable & Accrued Expense : $147.33 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Accounts Payable & Accrued Expense?

Alvotech's quarterly accounts payable & accrued expense declined from Jun. 2023 ($122.72 Mil) to Sep. 2023 ($55.57 Mil) but then increased from Sep. 2023 ($55.57 Mil) to Dec. 2023 ($147.33 Mil).

Alvotech's annual accounts payable & accrued expense increased from Dec. 2021 ($72.08 Mil) to Dec. 2022 ($87.84 Mil) and increased from Dec. 2022 ($87.84 Mil) to Dec. 2023 ($147.33 Mil).


Alvotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Alvotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Accounts Payable & Accrued Expense Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
- 28.81 72.08 87.84 147.33

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.84 32.12 122.72 55.57 147.33

Alvotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Alvotech (Alvotech) Business Description

Industry
Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Alvotech (Alvotech) Headlines

From GuruFocus

Alvotech to Participate in Jefferies Healthcare Conference

By GlobeNewswire GlobeNewswire 05-31-2023

Alvotech to Participate in Jefferies Healthcare Conference

By GlobeNewswire GlobeNewswire 05-31-2023